Simvastatin and MS: The Lancet Neurology: August 2017
The Lancet Neurology in conversation with - A podcast by The Lancet Group - Thursdays
Categories:
Jeremy Chataway discusses the surprising effects of simvastatin on patients with secondary progressive multiple sclerosis.Continue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv
